Global Naloxone Market to reach USD 819.7 million by 2026.

Global Naloxone Market Size Study By Product (Spray Forms, and Injectable Forms), By Application (Opioid Overdose, and Preventing Opioid Abuse, and Others), and By Regional (North America, Europe, Asia Pacific, Latin America, and Rest of the World) Forecasts, 2019-2026
Product Code:  HALDAT_95771100
Chapter 1.	Executive Summary 
1.1.	Market Snapshot
1.2.	Key Trends
1.3.	Global & Segmental Market Estimates & Forecasts, 2016-2026 (USD Billion)
1.3.1.	Naloxone Market, by Product, 2016-2026 (USD Billion)
1.3.2.	Naloxone Market, by Application, 2016-2026 (USD Billion)
1.3.3.	Naloxone Market, by Region, 2016-2026 (USD Billion)
1.4.	Estimation Methodology
1.5.	Research Assumption
Chapter 2.	Global Naloxone Market Definition and Scope 
2.1.	Objective of the Study
2.2.	Market Definition & Scope
2.2.1.	Industry Evolution
2.2.2.	Scope of the Study
2.3.	Years Considered for the Study
2.4.	Currency Conversion Rates
Chapter 3.	Global Naloxone Market Dynamics	
3.1.	See Saw Analysis
3.1.1.	Market Drivers
3.1.2.	Market Challenges
3.1.3.	Market Opportunities
Chapter 4.	Global Naloxone Market Industry Analysis
4.1.	Porter’s 5 Force Model
4.1.1.	Bargaining Power of Buyers
4.1.2.	Bargaining Power of Suppliers
4.1.3.	Threat of New Entrants
4.1.4.	Threat of Substitutes
4.1.5.	Competitive Rivalry
4.1.6.	Futuristic Approach to Porter’s 5 Force Model
4.2.	PEST Analysis
4.2.1.	Political Scenario
4.2.2.	Economic Scenario
4.2.3.	Social Scenario
4.2.4.	Technological Scenario
4.3.	Key Buying Criteria (On Demand)
4.4.	Regulatory Framework (On Demand)
4.5.	Investment Vs Adoption Scenario (On Demand)
4.6.	Analyst Recommendation & Conclusion
Chapter 5.	Global Naloxone Market, by Product 
5.1.	Market Snapshot 
5.2.	Market Performance - Potential Model
5.3.	Naloxone Market, Sub Segment Analysis
5.3.1.	  Spray Forms     
5.3.1.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
5.3.1.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
5.3.2.	 Injectable Forms
5.3.2.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
5.3.2.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
Chapter 6.	Global Naloxone Market, by Application          
6.1.	Market Snapshot 
6.2.	Market Performance - Potential Model
6.3.	Naloxone Market, Sub Segment Analysis
6.3.1.	  Opioid Overdose
6.3.1.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
6.3.1.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
6.3.2.	  Preventing Opioid Abuse
6.3.2.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
6.3.2.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
6.3.3.	 Other 
6.3.3.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
6.3.3.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
Chapter 7.	Global Naloxone Market, by Regional Analysis
7.1.	Naloxone Market, Regional Market Snapshot (2016-2026)
7.2.	North America Naloxone Market Snapshot
7.2.1.	U.S.
7.2.1.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
7.2.1.2.	 Product breakdown estimates & forecasts, 2016-2026 (USD Billion) 
7.2.1.3.	 Application breakdown estimates & forecasts, 2016-2026 (USD Billion)   
7.2.2.	Canada
7.2.2.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
7.2.2.2.	Product breakdown estimates & forecasts, 2016-2026 (USD Billion) 
7.2.2.3.	 Application breakdown estimates & forecasts, 2016-2026 (USD Billion)   
7.3.	Europe Naloxone Market Snapshot
7.3.1.	U.K. 
7.3.1.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
7.3.1.2.	Product breakdown estimates & forecasts, 2016-2026 (USD Billion) 
7.3.1.3.	 Application breakdown estimates & forecasts, 2016-2026 (USD Billion)   
7.3.2.	Rest of Europe
7.3.2.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
7.3.2.2.	Product breakdown estimates & forecasts, 2016-2026 (USD Billion) 
7.3.2.3.	 Application breakdown estimates & forecasts, 2016-2026 (USD Billion)   
7.4.	Asia Naloxone Market Snapshot
7.4.1.	China 
7.4.1.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
7.4.1.2.	Product breakdown estimates & forecasts, 2016-2026 (USD Billion) 
7.4.1.3.	 Application breakdown estimates & forecasts, 2016-2026 (USD Billion)   
7.4.2.	India 
7.4.2.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
7.4.2.2.	Product breakdown estimates & forecasts, 2016-2026 (USD Billion) 
7.4.2.3.	 Application breakdown estimates & forecasts, 2016-2026 (USD Billion)   
7.4.3.	Japan
7.4.3.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
7.4.3.2.	Product breakdown estimates & forecasts, 2016-2026 (USD Billion) 
7.4.3.3.	 Application breakdown estimates & forecasts, 2016-2026 (USD Billion)   
7.4.4.	Rest of Asia Pacific
7.4.4.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
7.4.4.2.	Product breakdown estimates & forecasts, 2016-2026 (USD Billion) 
7.4.4.3.	 Application breakdown estimates & forecasts, 2016-2026 (USD Billion)   
7.5.	Latin America Naloxone Market Snapshot
7.5.1.	Brazil 
7.5.1.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
7.5.1.2.	Product breakdown estimates & forecasts, 2016-2026 (USD Billion) 
7.5.1.3.	 Application breakdown estimates & forecasts, 2016-2026 (USD Billion)   

7.5.2.	Mexico 
7.5.2.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
7.5.2.2.	Product breakdown estimates & forecasts, 2016-2026 (USD Billion) 
7.5.2.3.	 Application breakdown estimates & forecasts, 2016-2026 (USD Billion)   
7.6.	Rest of The World 
7.6.1.	Middle East and Africa
7.6.1.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
7.6.1.2.	Product breakdown estimates & forecasts, 2016-2026 (USD Billion) 
7.6.1.3.	 Application breakdown estimates & forecasts, 2016-2026 (USD Billion)   
Chapter 8.	Competitive Intelligence
8.1.	Company Market Share (Subject to Data Availability)
8.2.	Top Market Strategies
8.3.	Company Profiles
8.3.1.	  Amphastar Pharmaceuticals
8.3.1.1.	Overview
8.3.1.2.	Financial (Subject to Data Availability)
8.3.1.3.	Product Summary
8.3.1.4.	Recent Developments
8.3.2.	   Pfizer
8.3.3.	ADAPT Pharma
8.3.4.	Kaleo
8.3.5.	Sandoz
8.3.6.	Amneal Pharmaceuticals
8.3.7.	West Ward Pharmaceuticals
8.3.8.	Mylan
8.3.9.	Angkor Data Communication Group Co., Ltd.
8.3.10.	Cybercomm
Chapter 9.	Research Process
9.1.	Research Process
9.1.1.	Data Mining
9.1.2.	Analysis
9.1.3.	Market Estimation
9.1.4.	Validation
9.1.5.	Publishing
9.1.6.	Research Assumption

Global Naloxone Market valued approximately USD 345 million in 2018 is forecasted to grow with a healthy growth rate of more than 11.40% over the forecast period 2019-2026. The major factors speculated to augment the markets rising availability of naloxone as a generic drug, and death cases from drug overdose increasing with alarmingly escalating rates. Continuous increase in prices of naloxone drug is a major constraint for the growth in market. Escalating engagement of private organizations and government in spreading cognizance regarding the availability of naloxone is a prime opportunity for growth in the market. Naloxone is a generic drug which is used to blocks or reverses the effects of opioid medication, including extreme drowsiness, slowed breathing, or loss of consciousness.
The regional analysis of Global Naloxone Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading region across the world in terms of market share. Furthermore, owing to countries such as China, India, and Japan, Asia Pacific region is also expected to exhibit higher growth rate / CAGR over the forecast period 2019-2026.
Major market player included in this report are:
Amphastar Pharmaceuticals
Pfizer
ADAPT Pharma
Kaleo
Sandoz
Amneal Pharmaceuticals
West Ward Pharmaceuticals
Mylan
Angkor Data Communication Group Co., Ltd.
Cybercomm

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

Spray Forms
Injectable Forms

By Application:

Opioid Overdose
Preventing Opioid Abuse
Others

By Regions:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026

Target Audience of the Naloxone Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors


We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Full Name*

Business Email* (Please avoid generic email IDs such as gmail, yahoo)

Phone* (Please Affix Country Code)

Need specific market information? To get a customized report, please share your exact research requirements.



Loading…